NG Bio, an early-stage investor and venture builder addressing the harmful immune responses, such as inflammation, that cause or exacerbate many of the major human diseases. By tackling these, we extend human health span and longevity. As scientists continue to unlock the secrets to the drivers of inflammation, NG Bio is creating the next generation of medicines and diagnostics in the breakthrough areas of cure, personalisation, regeneration, and women’s health. We partner with world leading entrepreneurs, research institutions and academic institutions across the globe to realise our vision of life with control over chronic diseases.
| Website | http://www.ngbio.co.uk |
| Employees | 6 (1 on RocketReach) |
| Founded | 2020 |
| Industry | Venture Capital and Private Equity Principals |
| Competitors | Thermo Fisher Scientific, Genentech, Agilent Technologies, Illumina, PerkinElmer, Inc., Bio-Rad Laboratories, QIAGEN, Bio-Techne, Meridian Bioscience Inc., Oxford Biosystems Ltd +36 more (view full list) |
Looking for a particular NG Bio employee's phone or email?
1 people are employed at NG Bio.
NG Bio is based in London, England.